Search
for
Sort by
Research 31–60 of 495
- Index
- Differential association between cumulative dose of 5α-reductase inhibitors and mortality
- A Series of Clinical Cases of Psychocutaneous Disorders in a Dermatology Unit in Albania
- Deteksi Dini dan Pencegahan Risiko Bunuh Diri pada Remaja
- Finasteride linked with suicidal ideation/self-harm
- Re: Association of Suicidality and Depression with 5α-Reductase Inhibitors
- Reframing the Discussion on Finasteride and Neuropsychiatric Safety
- Endocrine intervention for transsexuals
- Transgender adolescents and acne: A cases series
- Transsexualism
- Suicidal ideation in patients undergoing treatment with 5α-reductase inhibitors
- Finasteride-Induced Neuropsychiatric Reactions
- Failing Public Health Again? Analytical Review of Depression and Suicidality From Finasteride
- Transgender Competent Provider
- Depressive Symptoms and Suicidal Thoughts Among Former Users of Finasteride With Persistent Sexual Side Effects
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy
- Risk Factors and Epidemiology of Acne Severity and Acne Scar Development: A Comprehensive Clinical Study
- Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis
- Anabolic-androgenic steroids and cardiovascular risk
- Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis
- Suicidal behaviors (suicidal ideation, suicide attempt and completed suicide) in patients treated with finasteride for hair loss: Results from the U.S. FDA Adverse Event Reporting System (FAERS) database
- Considerations in genetic counseling of transgender patients: Cultural competencies and altered disease risk profiles
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- Do Sexual Orientation Change Efforts (SOCE) increase suicidal risk for sexual minorities?: An exchange
- Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
- Risk of Depression Associated With Finasteride Treatment
- Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
- Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis
- Testosterone therapy for transgender men